Lista de obras -

A case of premenopausal breast cancer with symptomatic cerebellar metastasis successfully treated by systemic endocrine therapy alone: relationship to biological features

artículo científico publicado en 2016

APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer

scientific article published on 17 July 2018

An integrative analysis of PIK3CA mutation, PTEN, and INPP4B expression in terms of trastuzumab efficacy in HER2-positive breast cancer

artículo científico publicado en 2014

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients

artículo científico publicado en 2017

C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.

artículo científico publicado en 2014

Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer

artículo científico publicado en 2017

Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up

scientific article published on 12 October 2011

Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients.

artículo científico publicado en 2016

Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer

scientific article published on 26 February 2018

Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients.

artículo científico

Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence

artículo científico publicado en 2017

Differential role of MACC1 expression and its regulation of the HGF/c‑Met pathway between breast and colorectal cancer.

artículo científico publicado en 2015

Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens.

artículo científico publicado en 2015

ESR1 and PIK3CA mutational status in serum and plasma from metastatic breast cancer patients: A comparative study

artículo científico publicado en 2018

Factors involved in early lenvatinib dose reduction: a retrospective analysis

artículo científico publicado en 2018

Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer

artículo científico publicado en 2016

HER2 Gene Amplification in ER-positive HER2 Immunohistochemistry 0 or 1+ Breast Cancer With Early Recurrence

artículo científico publicado en 2020

High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer

scientific article published on 28 December 2019

High expression of polo-like kinase 1 is associated with TP53 inactivation, DNA repair deficiency, and worse prognosis in ER positive Her2 negative breast cancer

scientific article published on 15 October 2019

Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy.

artículo científico publicado en 2015

Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor

scientific article published on 15 November 2019

Lenvatinib, an oral multi-kinases inhibitor, -associated hypertension: Potential role of vascular endothelial dysfunction.

artículo científico publicado en 2017

New evidence about thyroid cancer prevalence: prevalence of thyroid cancer in younger and middle-aged Japanese population

artículo científico publicado en 2013

PTIP associated protein 1, PA1, is an independent prognostic factor for lymphnode negative breast cancer.

artículo científico publicado en 2013

Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agents.

artículo científico publicado en 2009

Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients

artículo científico publicado en 2017

Prognostic role of PIK3CA mutations of cell-free DNA in early-stage triple negative breast cancer

artículo científico publicado en 2015

The Impact of Immunofunctional Phenotyping on the Malfunction of the Cancer Immunity Cycle in Breast Cancer

artículo científico publicado en 2020

The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer

artículo científico publicado en 2014

The ubiquitin E3 ligase activity of BRCA1 and its biological functions.

artículo científico publicado en 2008

Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling

scientific article published on 27 August 2018

[I. ESR1 Gene Alteration and Hormone Resistance in Breast Cancer]

artículo científico publicado en 2016

dPCR Mutational Analyses in Cell-Free DNA: A Comparison with Tissues

artículo científico publicado en 2019

Lista de obras de

A case of premenopausal breast cancer with symptomatic cerebellar metastasis successfully treated by systemic endocrine therapy alone: relationship to biological features

APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer

An integrative analysis of PIK3CA mutation, PTEN, and INPP4B expression in terms of trastuzumab efficacy in HER2-positive breast cancer

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients

C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.

Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer

Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up

Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients.

Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer

Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients.

Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence

Differential role of MACC1 expression and its regulation of the HGF/c‑Met pathway between breast and colorectal cancer.

Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens.

ESR1 and PIK3CA mutational status in serum and plasma from metastatic breast cancer patients: A comparative study

Factors involved in early lenvatinib dose reduction: a retrospective analysis

Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer

HER2 Gene Amplification in ER-positive HER2 Immunohistochemistry 0 or 1+ Breast Cancer With Early Recurrence

High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer

High expression of polo-like kinase 1 is associated with TP53 inactivation, DNA repair deficiency, and worse prognosis in ER positive Her2 negative breast cancer

Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy.

Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor

Lenvatinib, an oral multi-kinases inhibitor, -associated hypertension: Potential role of vascular endothelial dysfunction.

New evidence about thyroid cancer prevalence: prevalence of thyroid cancer in younger and middle-aged Japanese population

PTIP associated protein 1, PA1, is an independent prognostic factor for lymphnode negative breast cancer.

Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agents.

Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients

Prognostic role of PIK3CA mutations of cell-free DNA in early-stage triple negative breast cancer

The Impact of Immunofunctional Phenotyping on the Malfunction of the Cancer Immunity Cycle in Breast Cancer

The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer

The ubiquitin E3 ligase activity of BRCA1 and its biological functions.

Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling

[I. ESR1 Gene Alteration and Hormone Resistance in Breast Cancer]

dPCR Mutational Analyses in Cell-Free DNA: A Comparison with Tissues